{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:47:42Z","timestamp":1792511262070,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.xcrm.2026.103056","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T15:01:59Z","timestamp":1790089319000},"page":"103056","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting RPL4 improves the therapeutic efficacy of PD-L1 blockade in liver fibrosis"],"prefix":"10.1016","volume":"7","author":[{"given":"Jie","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Tong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"De-Hong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei-Da","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4362-6612","authenticated-orcid":false,"given":"Chuan-Ming","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2026.103056_bib1","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1016\/j.cgh.2023.04.015","article-title":"The Global Burden of Liver Disease","volume":"21","author":"Younossi","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.xcrm.2026.103056_bib2","doi-asserted-by":"crossref","first-page":"e701","DOI":"10.1016\/S2468-2667(23)00149-4","article-title":"Hepatitis B and C in Europe: an update from the Global Burden of Disease Study 2019","volume":"8","author":"Cortesi","year":"2023","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.xcrm.2026.103056_bib3","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.jhep.2021.02.012","article-title":"Targeting cell-intrinsic metabolism for antifibrotic therapy","volume":"74","author":"Gilgenkrantz","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.xcrm.2026.103056_bib4","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/s41419-023-06183-3","article-title":"The mechanism of linear ubiquitination in regulating cell death and correlative diseases","volume":"14","author":"Gao","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.xcrm.2026.103056_bib5","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s40779-023-00501-8","article-title":"Elevated FBXL6 activates both wild-type KRAS and mutant KRAS(G12D) and drives HCC tumorigenesis via the ERK\/mTOR\/PRELID2\/ROS axis in mice","volume":"10","author":"Xiong","year":"2023","journal-title":"Milit. Med. Res."},{"key":"10.1016\/j.xcrm.2026.103056_bib6","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1038\/s12276-023-01060-7","article-title":"Elevated FBXL6 expression in hepatocytes activates VRK2-transketolase-ROS-mTOR-mediated immune evasion and liver cancer metastasis in mice","volume":"55","author":"Zhang","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.xcrm.2026.103056_bib7","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s12964-020-00604-y","article-title":"FBXL6 governs c-MYC to promote hepatocellular carcinoma through ubiquitination and stabilization of HSP90AA1","volume":"18","author":"Shi","year":"2020","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.xcrm.2026.103056_bib8","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1038\/s41418-021-00739-6","article-title":"FBXL6 degrades phosphorylated p53 to promote tumor growth","volume":"28","author":"Li","year":"2021","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.xcrm.2026.103056_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2022.101550","article-title":"FBXL6 depletion restrains clear cell renal cell carcinoma progression","volume":"26","author":"Yu","year":"2022","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.xcrm.2026.103056_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14354","article-title":"Molecular basis for protection of ribosomal protein L4 from cellular degradation","volume":"8","author":"Huber","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.103056_bib11","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/s41419-021-03888-1","article-title":"PRDX2 promotes the proliferation of colorectal cancer cells by increasing the ubiquitinated degradation of p53","volume":"12","author":"Wang","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.xcrm.2026.103056_bib12","first-page":"315","article-title":"Gene expression profiling of human HBV- and\/or HCV-associated hepatocellular carcinoma cells using expressed sequence tags","volume":"29","author":"Yoon","year":"2006","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.xcrm.2026.103056_bib13","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1136\/gutjnl-2021-325065","article-title":"Targeting ER protein TXNDC5 in hepatic stellate cell mitigates liver fibrosis by repressing non-canonical TGFbeta signalling","volume":"71","author":"Hung","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.xcrm.2026.103056_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110349","article-title":"PD-L1 promotes myofibroblastic activation of hepatic stellate cells by distinct mechanisms selective for TGF-beta receptor I versus II","volume":"38","author":"Sun","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2026.103056_bib15","first-page":"806","volume":"138","author":"Wang","year":"2021","journal-title":"Upregulated PD-L1 delays human neutrophil apoptosis and promotes lung injury in an experimental mouse model of sepsis"},{"key":"10.1016\/j.xcrm.2026.103056_bib16","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.apsb.2020.09.007","article-title":"Phosphorylation regulates cullin-based ubiquitination in tumorigenesis","volume":"11","author":"Chen","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.xcrm.2026.103056_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41418-021-00827-7","article-title":"Global identification of phospho-dependent SCF substrates reveals a FBXO22 phosphodegron and an ERK-FBXO22-BAG3 axis in tumorigenesis","volume":"29","author":"Liu","year":"2022","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.xcrm.2026.103056_bib18","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation. Nature reviews","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.xcrm.2026.103056_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.874408","article-title":"New Drugs for Hepatic Fibrosis","volume":"13","author":"Shan","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.xcrm.2026.103056_bib20","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/hep.32285","article-title":"Hepatic fibrosis 2022: Unmet needs and a blueprint for the future","volume":"75","author":"Friedman","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.xcrm.2026.103056_bib21","article-title":"LncRNA SNHG7 accelerates the proliferation, migration and invasion of hepatocellular carcinoma cells via regulating miR-122-5p and RPL4","volume":"118","author":"Yang","year":"2019","journal-title":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie"},{"key":"10.1016\/j.xcrm.2026.103056_bib22","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1006\/nbdi.2000.0293","article-title":"Translational control of ribosomal protein L4 mRNA is required for rapid neurite regeneration","volume":"7","author":"Twiss","year":"2000","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.xcrm.2026.103056_bib23","doi-asserted-by":"crossref","first-page":"16217","DOI":"10.18632\/oncotarget.7479","article-title":"Ribosomal protein L4 is a novel regulator of the MDM2-p53 loop","volume":"7","author":"He","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.xcrm.2026.103056_bib24","first-page":"789","article-title":"Expression of ribosomal protein L4 (rpL4) during neurogenesis and 5-azacytidine (5AzC)-induced apoptotic process in the rat","volume":"17","author":"Ueno","year":"2002","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.xcrm.2026.103056_bib25","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1158\/0008-5472.CAN-18-4044","article-title":"LncRNA SNHG10 Facilitates Hepatocarcinogenesis and Metastasis by Modulating Its Homolog SCARNA13 via a Positive Feedback Loop","volume":"79","author":"Lan","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2026.103056_bib26","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nri.2017.108","article-title":"The diverse functions of the PD1 inhibitory pathway","volume":"18","author":"Sharpe","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2026.103056_bib27","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.3389\/fimmu.2019.02298","article-title":"The Diverse Function of PD-1\/PD-L Pathway Beyond Cancer","volume":"10","author":"Qin","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2026.103056_bib28","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2217\/imt-2017-0120","article-title":"PD-1\/PD-L1 in disease","volume":"10","author":"Kuol","year":"2018","journal-title":"Immunotherapy"},{"key":"10.1016\/j.xcrm.2026.103056_bib29","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jhep.2023.03.003","article-title":"Combination immunotherapy for hepatocellular carcinoma","volume":"79","author":"Rimassa","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.xcrm.2026.103056_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/0471141755.ph1430s66","article-title":"The DEN and CCl4 -Induced Mouse Model of Fibrosis and Inflammation-Associated Hepatocellular Carcinoma","volume":"66","author":"Uehara","year":"2014","journal-title":"Curr. Protoc. Pharmacol."},{"key":"10.1016\/j.xcrm.2026.103056_bib31","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/s41419-023-06077-4","article-title":"Expression of Cyclin E1 in hepatic stellate cells is critical for the induction and progression of liver fibrosis and hepatocellular carcinoma in mice","volume":"14","author":"Otto","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.xcrm.2026.103056_bib35","doi-asserted-by":"crossref","first-page":"106632","DOI":"10.1016\/j.intimp.2020.106632","article-title":"Isolation and purification of immune cells from the liver","volume":"85","author":"Shi","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.xcrm.2026.103056_bib32","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.70715","article-title":"Elevated FBXO45 promotes liver tumorigenesis through enhancing IGF2BP1 ubiquitination and subsequent PLK1 upregulation","volume":"10","author":"Lin","year":"2021","journal-title":"eLife"},{"key":"10.1016\/j.xcrm.2026.103056_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216257","article-title":"FBXW10-S6K1 promotes ANXA2 polyubiquitination and KRAS activation to drive hepatocellular carcinoma development in males","volume":"566","author":"Liu","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.xcrm.2026.103056_bib34","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/s41419-025-07849-w","article-title":"Diabetes is causally associated with increased breast cancer mortality by inducing FIBCD1 to activate MCM5-mediated cell cycle arrest via modulating H3K27ac","volume":"16","author":"Tan","year":"2025","journal-title":"Cell Death Dis."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126004738?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126004738?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:11:00Z","timestamp":1792509060000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379126004738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":35,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2666379126004738"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.103056","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting RPL4 improves the therapeutic efficacy of PD-L1 blockade in liver fibrosis","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.103056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103056"}}